Andere Kunden interessierten sich auch für
![Detection of Brain Tumor from MR Images Based on Co-occurrence Matrix]( "Detection of Brain Tumor from MR Images Based on Co-occurrence Matrix")
Detection of Brain Tumor from MR Images Based on Co-occurrence Matrix36,99 €![Matrix Tablet]( "Matrix Tablet")
Matrix Tablet32,99 €![Formulation of Sustain Release Matrix Tablet of Antiviral drug]( "Formulation of Sustain Release Matrix Tablet of Antiviral drug")
Formulation of Sustain Release Matrix Tablet of Antiviral drug26,99 €![Multi-scale Extracellular Matrix Mechanics and Mechanobiology]( "Multi-scale Extracellular Matrix Mechanics and Mechanobiology")
Multi-scale Extracellular Matrix Mechanics and Mechanobiology74,99 €![Levodopa and Carbidopa Controlled Release Matrix Tablets]( "Levodopa and Carbidopa Controlled Release Matrix Tablets")
Levodopa and Carbidopa Controlled Release Matrix Tablets32,99 €![The matrix Gla protein in vascular and osteoarticular pathologies]( "The matrix Gla protein in vascular and osteoarticular pathologies")
The matrix Gla protein in vascular and osteoarticular pathologies26,99 €![Expression of Matrix Metalloproteinase 2 and 9 in oral lichen planus]( "Expression of Matrix Metalloproteinase 2 and 9 in oral lichen planus")
Expression of Matrix Metalloproteinase 2 and 9 in oral lichen planus21,99 €
The aim of this study was to develop a lipid based formulation for a poorly soluble drug belonging to BCS Class II. The intention of the formulation design was to develop a self eroding matrix system made of lipidic excipients which would release the drug mainly by the mechanism of erosion. To attain such as system, lipidic excipients like stearic acid and hydrogenated castor oil were used as matrix formers and surfactants like sodium lauryl sulphate and gelucire 44/14 were used as matrix modifiers. The formulations prepared were subjected to physicochemical and in vitro dissolution and erosion studies.